# HAEMONETICS CORPORATION (HAE) FY2027 Q1 P&L / Income Statement

- Company: HAEMONETICS CORPORATION (HAE)
- Period: 2026-03-29 to 2026-06-27
- Filing: Q1 FY2027 10-Q, filed 2026-08-06, accession number 0000313143-26-000120
- Page: https://plicit.ai/financials/hae/fy2027-q1-income-statement
- Chart image: https://plicit.ai/charts/hae-fy2027-q1-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Product and Service

Income statement for 2026-03-29 through 2026-06-27. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenues**: 339,380,000 US dollars
- **Cost of goods sold**: 136,577,000 US dollars
- **Gross profit**: 202,803,000 US dollars
- **Total operating expenses**: 145,345,000 US dollars
- **Operating income**: 57,458,000 US dollars
- **Other income (expense), net (calculated)**: negative 9,884,000 US dollars
- **Income before provision for income taxes**: 47,574,000 US dollars
- **Provision for income taxes**: 14,564,000 US dollars
- **Net income**: 33,010,000 US dollars
- **Apheresis - Plasma**: 155,524,000 US dollars
- **Apheresis - Other**: 35,794,000 US dollars
- **MedSurg - Blood Management Technologies**: 88,120,000 US dollars
- **MedSurg - Interventional Technologies**: 59,942,000 US dollars
- **Research and development**: 16,200,000 US dollars
- **Selling, general and administrative**: 118,941,000 US dollars
- **Amortization of acquired assets**: 10,204,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/hae/fy2027-q1-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/hae-fy2027-q1-revenue-by-business-segment-sankey.png

Income statement for 2026-03-29 through 2026-06-27. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenues**: 339,380,000 US dollars
- **Cost of goods sold**: 136,577,000 US dollars
- **Gross profit**: 202,803,000 US dollars
- **Total operating expenses**: 145,345,000 US dollars
- **Operating income**: 57,458,000 US dollars
- **Other income (expense), net (calculated)**: negative 9,884,000 US dollars
- **Income before provision for income taxes**: 47,574,000 US dollars
- **Provision for income taxes**: 14,564,000 US dollars
- **Net income**: 33,010,000 US dollars
- **Apheresis**: 191,318,000 US dollars
- **MedSurg**: 148,062,000 US dollars
- **Research and development**: 16,200,000 US dollars
- **Selling, general and administrative**: 118,941,000 US dollars
- **Amortization of acquired assets**: 10,204,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/hae/fy2027-q1-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/hae-fy2027-q1-revenue-by-geography-sankey.png

Income statement for 2026-03-29 through 2026-06-27. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenues**: 339,380,000 US dollars
- **Cost of goods sold**: 136,577,000 US dollars
- **Gross profit**: 202,803,000 US dollars
- **Total operating expenses**: 145,345,000 US dollars
- **Operating income**: 57,458,000 US dollars
- **Other income (expense), net (calculated)**: negative 9,884,000 US dollars
- **Income before provision for income taxes**: 47,574,000 US dollars
- **Provision for income taxes**: 14,564,000 US dollars
- **Net income**: 33,010,000 US dollars
- **UNITED STATES**: 257,844,000 US dollars
- **JAPAN**: 12,858,000 US dollars
- **Europe**: 45,529,000 US dollars
- **Rest of Asia**: 20,163,000 US dollars
- **Other**: 2,986,000 US dollars
- **Research and development**: 16,200,000 US dollars
- **Selling, general and administrative**: 118,941,000 US dollars
- **Amortization of acquired assets**: 10,204,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.